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The aim of this article is two-fold: to report the prevalence of herbal products used by pregnant women and
to evaluate the evidence of efficacy and safety of the most popular remedies.
Recent findings
Of the 671 articles identified, 15 randomized controlled trials (RCTs) and 16 non-RCTs were eligible.
Ginger was the most investigated remedy and it was consistently reported to ameliorate nausea and
vomiting in pregnancy. Although raspberry, blue cohosh, castor oil, and evening primrose oil are believed
to facilitate labor in traditional medicine, very few scientific data support such indication. Moreover, they
have been associated with severe adverse events. Data on the safety of Hypericum perforatum in
pregnancy or lactation are reassuring, whereas efficacy was demonstrated only in nonpregnant
individuals. There is still insufficient evidence regarding the efficacy and safety of Echinacea, garlic, and
cranberry in pregnancy.
Summary
Epidemiological studies reported a wide range of use of herbal remedies in pregnancy. Too few studies
have been devoted to the safety and efficacy of singular herbs. With the exception of ginger, there are no
consistent data to support the use of any other herbal supplement during pregnancy. Severe adverse events
have been reported using blue cohosh and evening primrose oil.
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A search of the literature in electronic databases
(Medline, Amed, The Cochrane Library, and the
PDR for Herbal Medicines) from 1970 to 2013, using
the keywords ‘herbal treatments’, ‘herbal remedies’,
‘herbal supplements’, and ‘pregnancy’, found 703
articles, 515 of them published during 2000–2013,
156 between 1990 and 1999, 57 in the 1980s, and
just 5 studies in the 1970s. This emphasizes the
growing interest in the subject with the newmillen-
nium together with the increased utilization of
herbal remedies by the general population [1
&
]. As
for many other complementary alternative medi-
cines women result themajor consumers [2] and it is
not surprising that they could continue herbs use
also during gestation [2]. Such remedies are most
often used to counteract minor complaints like
nausea, vomiting, constipation, anxiety, or back-
ache. However, herbs are also claimed (and used)
to solve urinary tract infections (UTIs) or to induce
or accelerate labor [3–5].
Pregnant women are apprehensive about the
potential toxicity of conventional medicines, so
they use herbal products to complement or to
replace them, although much current practice isilliams & Wilkins. Unau
Health | Lippincott Williams & Wilkinot evidence based [2,3]. Indeed, there is evidence
of the negative effects associated with the use of
some herbal remedies, and data on safety for their
use in pregnancy are limited [6,7].
Although herbal medicines contain active con-
stituents with pharmacological properties and
possible interactions with other compounds, they
are considered by women natural and safer than
conventional drugs [2,5].
Another issue is that herbal products are over
the counter and offer women greater independence
for their health-care choices [8,9]. Hence, the
majority of consumers do not disclose their use to
the doctor and rely on family and friends or websites
for information regarding such treatments [2,8].
The aim of this article is two-fold: to report the
prevalence of herbal products used by pregnantthorized reproduction of this article is prohibited.
ns www.co-obgyn.com
CKEY POINTS
 About half of pregnant women try a wide range of
herbal treatments, although the efficacy and safety of
such remedies are poorly known.
 Ginger relieves nausea and vomiting in pregnancy,
similarly to vitamin B6 or dimenhydrinate.
 Blue cohosh and primrose oil have been associated
with severe fetal complications, whereas their efficacy
remains to be demonstrated.
 There is still insufficient efficacy and safety evidence
supporting the clinical use of Echinacea, garlic,
and cranberry.
 St John’s wort use in pregnancy or lactation is reported
to be well tolerated.
Maternal–fetal medicinewomen and to evaluate the evidence of efficacy and
safety of the most popular remedies.METHODS
A systematic literature search was performed in
October 2013 in the Medline electronic database.
We performed a search about herbal treatments,
their applications, and potential effects in preg-
nancy over the period 1990–2013.
As specified previously, the search terms
were ‘herbal treatments’, ‘herbal remedies’, ‘herbal
supplements’, and ‘pregnancy’. The search was lim-
ited to articles published in the English language
and those that were easily retrievable via the home
library. Further relevant studies, in particular about
the search of randomized controlled trials (RCTs),
were located by hand searching the reference lists of
the recent systematic reviews.
For inclusion, an article had to contain
original data on either the prevalence of use or
adverse effects of herbal treatments during
pregnancy.
Only human studies were included, data from
herbal treatments in combination with other herbs
or multivitamins as well as animal and in-vitro
investigations were excluded.
Fertility treatments, contraception, and the
deliberate use of herbal medicine products as abor-
tifacients were also excluded. Topical treatments
were included.
We attempted to obtain hard copies of all the
studies listed through our own university library or
interlibrary loans.
Expert judgement, rather than a formal quality
appraisal, was used to determine which studies
were included.opyright © Lippincott Williams & Wilkins. Unautho
84 www.co-obgyn.comIn the first section, we analyzed only epidemio-
logical data and in the second section, we examined
the use and efficacy of single herbal treatments.
All sources of information were read and eval-
uated by one of us (G.D.), and later independently
checked by another author (G.B.). Data were
extracted according to the predefined criteria and
are represented in different tables.RESULTS
The decision tree used for the inclusion of the
studies about the most investigated herbal products
is presented in Fig. 1.
Out of the 671 articles published during the last
2 decades (1990–2013), 258 were excluded from the
analysis as they described Chinese herbal remedies.
Only 15 studies reported RCTs, 14 of them have
been described in detail in a previous publication
[7].
The features of the single herbal treatments
originating in the RCT trials are reported in Table 1
[10–24]. Moreover, efficacy and safety of single-herb
remedies originating from the observational studies
are described in Table 2 [25,26
&
,27–40].MOST POPULAR HERBAL REMEDIES
Twenty-two articles were screened [41–58,59
&
,
60–62], 16 of them concerning only the use of
herbal treatments and six pertaining the employ-
ment of complementary alternative medicines
(CAM), whereas two [61,62] were excluded from this
analysis because of duplicate publications.
Out of the remaining 20 studies, 13 were obser-
vational, two case–control, and five cross-sectional
studies. All the studies were conducted between
1997 and 2013, and all the data were obtained from
self-administered questionnaires or from a prestruc-
tured questionnaire through a face-to-face interview
performed during pregnancy or 2–3 days after the
delivery. Only in three cases, the questionnaire was
administered by a telephone call after a variable
time after delivery (from 2 weeks to 8 years).
Most of the published data were collected in
Europe [46,48,54,55,59
&
] or in the USA [42,43,45,
50–52].
Estimates of frequency of use of herbal treat-
ments during pregnancy range from 0.9 [48] to 87%
[41], and such differences could be related to the
study designs, data collectionmethods, and cultural
characteristics of the investigated population.
According to the results from other reviews
[9,63], women using herbal remedies were more
likely to be Caucasian, middle-aged, nonsmokers,
and with a high level of education. Only two studiesrized reproduction of this article is prohibited.
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671 Articles idenitified
413 Screened
55 Eligible for
single products
 – 22 From medline
 – 33 From reference lists
31 Articles included:
 – 15 RCTs
 – 5 Prospective observational studies
 – 1 Retrospective observational study
 – 4 Cohort studies
 – 5 Case reports
 – 1 Quasi-experimental study
24 Excluded
 – 23 Reviews/overviews
 – Abstract
22 Eligible for
epidemiological data
258 Excluded since
chinese herbal
treatments
FIGURE 1. Flow chart of examined studies.
Herbal therapies in pregnancy: what works? Dante et al.described the women’s employment status [54,60]
andwe cannot summarize this characteristic as it is a
socio-cultural feature of the population.
From the analysis of these studies, we summar-
ize in Table 3 the 12 herbs most frequently con-
sumed by pregnant women.MOST INVESTIGATED HERBAL REMEDIES
We screened 391 articles describing single-herb
remedies and we located other studies by hand
searching the reference lists of the most recent
reviews.
With this combined search, we found 15 RCTs
[10–24] (Table 1), five prospective observational
studies [25,28–31], one retrospective observational
study [27], four cohort studies [26
&
,36–38], five case
reports [33–35,40], and a quasi-experimental study
[39] (Table 2).
Twelve articles explored the effect of ginger
[10–19,25,26
&
], five studied St. John’s wort [21,29–
32], three investigated blue cohosh [33–35], another
three castor oil [24,37,38], two evaluated raspberry
leaf [22,27], two garlic [23,36], two primrose oil
[39,40], and two other studies reported cranberryCopyright © Lippincott Williams & Wilkins. Unau
1040-872X  2014 Wolters Kluwer Health | Lippincott Williams & Wilkiand Echinacea, respectively [20,28]. Ten of the
non-RCTs investigated only the safety of the herbal
products [25,26
&
,29–35,40].Ginger
Ginger was thoroughly investigated in 10 RCTs
[10–19], one prospective observational study [25],
and one cohort study [26
&
]. The primary objective of
the RCTs was to investigate the effectiveness of
ginger on nausea and vomiting during pregnancy,
whereas the primary outcome of the observational
studies was to examine the safety of this product on
congenital malformations and some pregnancy out-
comes. Five RCTs reported the superiority of ginger
compared with placebo [10–14], whereas four other
trials found ginger to be equally effective when
compared to vitamin B6 [15,16,18,19] and dimen-
hydrinate [17].
There were no significant differences between
ginger and the other treatments with respect to
adverse events and no increased risk for major
malformations, stillbirth/perinatal death, preterm
birth, low birth weight, or low Apgar score
[25,26
&
].thorized reproduction of this article is prohibited.
ns www.co-obgyn.com 85
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Table 3. Herbs most frequently used in pregnant women
and reasons for their use (reported in alphabetical order)
Herb Reasons for use
Almond oil Stretch marks
Aloe Digestive problems, constipation, capillary frailty
Chamomile Anxiety, digestive problems, relax, sleep
Cranberry Treat and prevent urinary tract infections
Echinacea Common cold, strengthen immune system
Fennel Fluid retention
Ginger Nausea, vomiting
Peppermint Indigestion/heartburn, nausea/morning sickness
Raspberry leaf Induce and ease labor
St. John’s wort Depression
Teas/green tea Anxiety, digestive problems, constipation
Valerian Anxiety
Maternal–fetal medicine
88 www.co-obgyn.comRaspberry
The use of raspberry to induce and ease labor was
described in one RCT [22] and one retrospective
observational study [27]. In both the studies,
raspberry did not shorten the first stage of labor.
The only clinically significant finding was the short-
ening of the second stage of labor with lower rate of
forceps deliveries compared with placebo.
The use of raspberry was not associated with
maternal–fetal adverse events.St. John’s wort
There were four observational studies regarding the
use of St. John’s wort in the treatment of mild and
moderate depression [29–32], two of them were
conducted during pregnancy [29,32] and two during
lactation [30,31]. The purpose of these studies was to
determine whether exposure to this agent in preg-
nancy was associated with major fetal malfor-
mations or with infant adverse events. The use of
St. John’s wort was found to bewell tolerated in both
conditions. Only one RCT [21] was performed to
determine the effects of a topical preparation on
cesarean wound healing. At 10th day postpartum, St
John’s wort facilitated cesarean wound healing and
minimized the formation of scar. In addition, sig-
nificantly lower pain and pruritus were reported by
the treatment group at the 40th day postpartum.Garlic
One RCT [23] analyzed the effects of garlic on the
prevention of preeclampsia in high-risk women.
There was a reduction in the total cholesterol level,
whereas neither hypertension nor preeclampsia was
reduced.rized reproduction of this article is prohibited.
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Herbal therapies in pregnancy: what works? Dante et al.Minor adverse events such as a foul odor and
nausea were reported in the garlic users, no effect
was found on neonates.
One observational cohort study [36] demon-
strated that garlic intake was associated with a
lower risk of both early and late preterm delivery.
Maternal–fetal adverse events were not analyzed.Cranberry
Only one RCT [20] compared cranberry extract
with placebo in the prevention of UTIs. A non-
significant reduction in the frequency of both
asymptomatic bacteriuria and UTIs was reported
in women receiving cranberry. The study,
however, was not sufficiently powered to detect
such a difference. Moreover, 38.8% of the parti-
cipants withdrew, mostly because of gastro-
intestinal upset. There was no difference between
groups with respect to obstetric and neonatal out-
comes.Blue cohosh
This remedy is expected to induce and accelerate
labor.
Only three case reports are available and they
described cardiovascular side-effects using blue
cohosh at the time of delivery [33–35]. In one
case, the neonate experienced acute myocardial
infarction, profound congestive heart failure, and
shock [33]; in another case, there was a severe multi-
organ hypoxic injury [35]; and in the last one,
perinatal stroke occurred [34].
No studies are available on efficacy.Echinacea
One prospective observational study [28] evaluated
the safety and the efficacy of Echinacea when used
during the first trimester for upper respiratory tract
ailments. No increased risk of major malformations
was reported. Respiratory symptoms improved with
respect to nontreated group.Castor oil
There were two observational studies [37,38] and
one RCT [24] about the effect of castor oil on the
induction of labor. The RCT showed a significant
increase in labor initiation in the treated group
compared with controls and the same outcome
was found in the prospective study by Garry et al.
[38]. However, in the study by Boel et al. [37], castor
oil showed no effect on the time of birth. Nauseawas
the most common maternal side-effect reported.Copyright © Lippincott Williams & Wilkins. Unau
1040-872X  2014 Wolters Kluwer Health | Lippincott Williams & WilkiThere were no data on neonatal mortality or mor-
bidity.Evening primrose oil
Evening primrose oil is a fatty acid used to trigger
cervical ripening.
In a retrospective study of quasi-experimental
design [39], this product did not shorten gestation
or decrease the overall length of labor; moreover,
it increased the incidence of prolonged rupture
of membranes, oxytocin augmentation, arrest of
descent, and vacuum extraction.
There was one case of petechiae and ecchymosis
in a newborn, whose mother took primrose oil a
week before giving birth [40].CONCLUSION
Epidemiological studies on the use of herbal rem-
edies in pregnancy reported a wide range of use.
However, some of these studies are limited by
methodological flaws (lack of prestructured ques-
tionnaires/interviews, recall bias, etc.). Excluding
them, it is reasonable to conclude that the consump-
tion of herbal remedies during pregnancy ranges
from 27 to 57% in Europe and from 10 to 73% in
the USA.
Anxiety is one of the most frequent reasons for
use. Indeed, there are at least three herbs claimed
as anxiety relievers, that is, chamomile, teas, and
valerian. For none of them is there a scientific
demonstration of efficacy, apart from the traditional
beliefs.
On the contrary, the popular use of ginger for
the relief of hyperemesis gravidarum has been sub-
stantiated by clinical trials which demonstrated
the antiemetic effect of ginger also in a number of
other clinical indications, including chemotherapy-
induced nausea [64], motion sickness [65,66], and
postoperative nausea [67,68].
The active compound allowing the antinausea
and antiemetic mechanism of ginger has not
been fully identified, and it has variously been
attributed to the gingerols, shogaol, or zingiberene
content. Mechanism of action included serotonin
antagonism and vasopressin suppression to reduce
tachygastric activity and to be weakly cholinergic
[69].
Some studies in nonpregnant women show
that ginger has an anticoagulant effect and women
taking anticoagulant therapy should avoid it com-
pletely [70,71]. Furthermore, ginger is known to be a
stomach irritant, and stimulates the secretion of bile
being contraindicated in people with a history of
gallstones [72]. Finally, it should be avoided inthorized reproduction of this article is prohibited.
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CMaternal–fetal medicinewomen with diabetes mellitus, who are controlled
through oral antidiabetics or insulin [73] and it may
cause hypotension [69].
Although raspberry, blue cohosh, castor oil, and
evening primrose oil are believed to facilitate labor
in traditional medicine, very few scientific data are
available to support such indication. Raspberry leaf
as well as evening primrose oil has proven ineffec-
tive, the latter arising doubts about safety. Labor
induction with castor oil seems promising and fur-
ther studies will help to comprehend the available
contrasting data.
Of paramount importance is the alarm signal
toward blue cohosh. Efficacy as labor stimulant is
lacking, although a significant number of U.S. mid-
wives use it [74]. On the contrary, three case reports
describe significant adverse events in neonates
whose mother received the herb remedy [33–35].
The efficacy of St John’s wort in the treatment of
mild-to-moderate depression has been assessed in
nonpregnant women and men [75]. Current evi-
dence suggests that at least two of the herb constitu-
ents, hypericin and hyperforin, play a significant
role in this pharmacologic effect [76,77]. Data on its
use in pregnancy or lactation reassure about safety,
whereas efficacy was not specifically reported.
There is still insufficient evidence to make any
conclusions regarding Echinacea, garlic, and cran-
berry in pregnancy, although the efficacy of the
latter in preventing the recurrence of UTIs has been
well demonstrated in nonpregnant women [78].
Furthermore, it is necessary to highlight the
adverse events associated with the prolonged use
of almond oil. Despite the absence of studies
devoted to this compound, in a survey performed
in postpartum women it was found that those who
applied almond oil to their abdomen daily (to avoid
stretch marks) were at higher risk for preterm deliv-
ery [59
&
].
In conclusion, despite the very large popular use
of herbal remedies during pregnancy, there are very
few studies that have been devoted to the specific
evaluation of these treatments. With the exception
of ginger supplementation for hyperemesis gravida-
rum, there is actually no clinical indication for the
use of any other herbal treatment in pregnant
women. Vice versa, caution on the use of several
compounds because of poor safety is available from
case reports and epidemiological studies.
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